The high nuclear NOTCH2 activity is not only a hallmark of all CLL cases—where it is associated with the expression of the B-cell activation/differentiation marker CD23—but is also functionally linked with CLL cell viability [7,8,18]. Here, FCER2 is linked to B-cell chronic lymphocytic leukemia.